The Company Behind Tylenol Tries to Navigate Its Latest Crisis

nytimes.com/2025/09/22/health/tylenol-autism-kenvue.html

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.

This story appeared on nytimes.com, 2025-09-22 20:10:28.
The Entire Business World on a Single Page. Free to Use →